Clinical trial
A Pilot Study Utilizing Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
NCT00530192 is registered in ClinicalTrials.gov with Scottsdale Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study Utilizing Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers
- Lead sponsor
- Scottsdale Healthcare
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- March 31, 2009
- Enrollment
- 86 (actual)
- Sites
- 9
Conditions
As the registry lists them; a condition with its own page is linked.
refractory cancer